Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study

Transarterial chemoembolization(TACE) is the palliative treatment of choice for patients with unresectable hepatocellular carcinoma (HCC). The 242 patients prospectively enrolled in this study were diagnosed with HCC and received TACE at Sun Yat-Sen University Cancer Center between October 2014 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhong-Guo, Chen, Jin-Bin, Qiu, Hai-Bo, Wang, Ruo-Jing, Chen, Jian-Cong, Xu, Li, Chen, Min-Shan, Zhang, Yao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053700/
https://www.ncbi.nlm.nih.gov/pubmed/27056892
http://dx.doi.org/10.18632/oncotarget.8560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053700/
https://www.ncbi.nlm.nih.gov/pubmed/27056892
http://dx.doi.org/10.18632/oncotarget.8560

Ejemplares similares